A study conducted by researchers from Aix-Marseille University in France has revealed a new way to track disease progression of Charcot-Marie-Tooth disease type 1a (CMT1a)– changes to the nerves within the thigh. These changes were found to be correlated with clinical disability in patients. This means that nerve tissue could not only help to monitor progression, it could also be used to determine how effective a treatment is for patients.
This study was published in the European Journal of Neurology.
About CMT1a
CMT1a affects the myelin surrounding the nerve cells. It slows the nerve signal’s transmission from the muscles to the brain and the brain to the muscles. Symptoms include muscle weakness, which is progressive, muscle atrophy, and a decrease in sensation.
Currently, there are no therapies which target the root cause of the disease. Further, doctors have found it difficult to track the progression of disease.
The Study
This study used a quantitative MRI to assess the nerve tissue. This type of technology is very sensitive to how the cells change over time.
The researchers compared the results of this test in CMT1a patients (32) as well as healthy volunteers (13). The controls were matched to the patients by their sex and age. On average, patients had been diagnosed for 25 years and were 37.5 years old. For most, symptoms began in their childhood. They measured the following in both the thigh and the leg-
- Nerve volume
- Proton density
- Magnetization Transfer Ratio
They wanted to uncover whether these impacted-
- Functional disability in patient’s daily life (using ONLS and ONLSL)
- Muscle strength
- Disease severity
- Clinical disability
Results
The team found that both nerve volume and the proton density were higher for CMT1a patients than the controls in the study. This was true for both the thigh and leg region. However, the magnetization transfer ratio was lower for patients in both.
Overall, the researchers determined that the thigh’s nerve volume was correlated with all of the clinical measures. The same was not true for the other nerve region. Proton density in the nerve was also correlated with functional disability measures. The magnetization transfer ratio was correlated to the strength of the quadriceps. These findings and others mean that the qMRI measurements for the thigh may be the best measurements for assessing disease progression and therapeutic progress.
Looking Forward
Greater research into nerve tissue is needed, but this research is certainly promising. This means longitudinal studies are needed to assess progression and changes during treatment.
You can read more about this ongoing research and its progress here.